News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
59,706 Results
Type
Article (1598)
Company Profile (6)
Press Release (58102)
Section
Business (27984)
Career Advice (34)
Deals (4281)
Drug Delivery (3)
Drug Development (6280)
Employer Resources (9)
FDA (1021)
Job Trends (1508)
News (37777)
Policy (2033)
Tag
Academia (107)
Accelerated approval (2)
Adcomms (3)
Allergies (13)
Alliances (2004)
ALS (7)
Alzheimer's disease (84)
Antibody-drug conjugate (ADC) (45)
Approvals (1082)
Artificial intelligence (19)
Autoimmune disease (22)
Automation (1)
Bankruptcy (15)
Best Places to Work (1439)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (6)
Bladder cancer (59)
Breast cancer (111)
Cancer (664)
Cardiovascular disease (53)
Career advice (33)
CAR-T (30)
CDC (5)
Cell therapy (69)
Cervical cancer (7)
Clinical research (6015)
Collaboration (91)
Compensation (73)
Complete response letters (4)
COVID-19 (179)
CRISPR (4)
C-suite (32)
Cystic fibrosis (5)
Data (821)
Depression (10)
Dermatology (9)
Diabetes (42)
Diagnostics (595)
Digital health (4)
Diversity, equity & inclusion (3)
Drug discovery (13)
Drug pricing (5)
Duchenne muscular dystrophy (39)
Earnings (27059)
Editorial (5)
Employer branding (4)
Employer resources (9)
Events (5785)
Executive appointments (25)
FDA (1507)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (6)
Funding (77)
Gene editing (7)
Generative AI (1)
Gene therapy (44)
GLP-1 (67)
Government (288)
Grass and pollen (2)
Guidances (249)
Healthcare (1736)
HIV (9)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (22)
Immuno-oncology (9)
Indications (17)
Infectious disease (235)
Inflammatory bowel disease (12)
Inflation Reduction Act (1)
Influenza (12)
Intellectual property (12)
Interviews (2)
IPO (3335)
Job creations (135)
Job search strategy (32)
JPM (2)
Kidney cancer (2)
Labor market (5)
Layoffs (16)
Legal (330)
Liver cancer (6)
Lung cancer (87)
Lymphoma (70)
Manufacturing (46)
MASH (17)
Medical device (1541)
Medtech (1547)
Mergers & acquisitions (1026)
Metabolic disorders (90)
mRNA (6)
Multiple sclerosis (12)
NASH (5)
Neurodegenerative disease (12)
Neuropsychiatric disorders (10)
Neuroscience (170)
NextGen: Class of 2026 (378)
Non-profit (199)
Now hiring (2)
Obesity (34)
Opinion (7)
Ovarian cancer (33)
Pain (28)
Pancreatic cancer (25)
Parkinson's disease (18)
Patents (28)
Patient recruitment (29)
Peanut (4)
People (1786)
Pharmacy benefit managers (2)
Phase 1 (1333)
Phase 2 (2396)
Phase 3 (2714)
Pipeline (1743)
Policy (6)
Postmarket research (221)
Preclinical (374)
Press Release (5)
Prostate cancer (28)
Psychedelics (2)
Radiopharmaceuticals (28)
Rare diseases (55)
Real estate (168)
Recruiting (5)
Regulatory (1792)
Reports (5)
Research institute (117)
Resumes & cover letters (1)
Rett syndrome (2)
RSV (40)
Schizophrenia (17)
Series A (4)
Series B (5)
Sickle cell disease (8)
Special edition (1)
Spinal muscular atrophy (4)
Startups (77)
Stomach cancer (4)
Supply chain (2)
Tariffs (1)
Vaccines (76)
Venture capital (1)
Weight loss (18)
Women's health (8)
Worklife (1)
Date
Last 7 days (72)
Last 30 days (335)
Last 365 days (3708)
2026 (921)
2025 (3777)
2024 (4134)
2023 (5058)
2022 (5633)
2021 (6039)
2020 (5436)
2019 (3891)
2018 (3009)
2017 (2526)
2016 (2027)
2015 (2923)
2014 (2001)
2013 (1175)
2012 (1267)
2011 (1476)
2010 (1299)
Location
Africa (37)
Alabama (5)
Arizona (21)
Asia (3099)
Australia (412)
California (1545)
Canada (318)
China (134)
Colorado (88)
Connecticut (61)
Delaware (70)
Europe (9457)
Florida (214)
Georgia (66)
Idaho (3)
Illinois (104)
India (4)
Indiana (82)
Japan (55)
Kansas (10)
Kentucky (8)
Louisiana (11)
Maine (15)
Maryland (194)
Massachusetts (925)
Michigan (30)
Minnesota (125)
Missouri (18)
Montana (4)
Nevada (15)
New Hampshire (10)
New Jersey (506)
New York (379)
North Carolina (164)
Northern California (784)
Ohio (36)
Oklahoma (1)
Pennsylvania (336)
South America (79)
South Carolina (1)
Southern California (637)
Tennessee (18)
Texas (201)
United States (5338)
Utah (48)
Virginia (51)
Washington D.C. (3)
Washington State (100)
Wisconsin (9)
59,706 Results for "74".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study for Pancreatic Cancer
February 11, 2026
·
3 min read
Press Releases
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study
December 29, 2025
·
5 min read
Press Releases
Cell and Gene Therapy CDMO Market Size Worth USD 74.03 Billion by 2034
December 5, 2025
·
1 min read
Press Releases
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
December 9, 2025
·
11 min read
Press Releases
Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 V617F, into First-in-Human Clinical Development
December 18, 2025
·
4 min read
Press Releases
Ivonescimab HARMONi-A Study Final OS Analysis Results Presented at SITC 2025 with OS HR=0.74
November 10, 2025
·
7 min read
Press Releases
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
December 12, 2025
·
8 min read
Press Releases
Cure Rare Disease Awarded $7.4 Million CIRM Grant to Advance Gene Therapy for Limb-Girdle Muscular Dystrophy Type 2i/R9
December 16, 2025
·
3 min read
Press Releases
Herbal Medicinal Products Market to Hit $326.46 Billion by 2032, at a CAGR of 7.4%, says Coherent Market Insights
November 3, 2025
·
1 min read
Press Releases
Johnson & Johnson’s INLEXZO™ (gemcitabine intravesical system) delivers 74 percent disease-free survival at one year in BCG-unresponsive, high-risk, papillary-only NMIBC
December 8, 2025
·
12 min read
1 of 5,971
Next
